6% THC, 11% CBD: Symptom Matched Migraine Strains in Alameda County

For most people with migraine, the smartest starting point is a CBD-forward or balanced CBD:THC product: inhalation for fast rescue during an attack, low-dose oral forms for prevention between attacks. A randomized crossover trial found vaporized THC+CBD outperformed placebo for acute relief. Track how often you use rescue products, and talk to a clinician if you need them more than 2 to 3 days a week.

TL;DR:

• Vaporized THC and CBD at a 6% THC and 11% CBD ratio have shown consistent relief at 2, 24, and 48 hours during migraine attacks.
• Using rescue cannabis more than two to three days weekly risks medication overuse headache and should be carefully monitored with a diary.
• Products with balanced or CBD-dominant ratios are preferable for acute relief or prevention, especially for those sensitive to THC side effects.
• Terpenes like myrcene and beta-caryophyllene may improve pain and inflammation, but strain names are less reliable than lab-verified cannabinoid and terpene profiles.
• Inhalation offers the fastest relief, while oral forms like tinctures and edibles provide longer-lasting effects, but require cautious dosing and tracking.

Table of Contents

• Why cannabis may help with migraine
• When cannabis can worsen headaches instead of easing them
• Which cannabinoids and terpenes actually matter
• Choosing products by your dominant migraine symptom
• How to dose by method, step by step
• Safety checklist and when to call a clinician
• Where this guidance comes from and how to verify it
• What the evidence actually supports, and where advice overshoots it
• Try a lab-tested product matched to your migraine pattern
• Sources
• FAQ

Why cannabis may help with migraine

The case for cannabis in migraine rests on a mix of receptor biology and a small but meaningful body of trial evidence. Migraine involves overactive pain signaling, inflammation, and a molecule called CGRP that drives attacks. Cannabinoids interact with CB1 and CB2 receptors found throughout the nervous system, and some research on phytocannabinoids and migraine points to CGRP modulation and even PPAR receptor involvement as part of the mechanism. There is also a theory that some people with chronic migraine have naturally low levels of their own endocannabinoids, which would make plant-based cannabinoids more noticeable when they step in.

The strongest clinical evidence so far comes from a double-blind, placebo-controlled crossover trial published in Neurology. Participants used vaporized flower containing 6% THC and 11% CBD to treat migraine attacks as they happened, and the combination beat placebo on several measures at the two-hour mark.

The majority of THC+CBD-treated attacks achieved pain relief at 2 hours compared with placebo, and the benefit held up at 24 and 48 hours in the same trial. That gap is large enough to matter clinically, not just statistically.

A related crossover study registered on PMC enrolled 92 participants who treated 247 attacks across randomized conditions of THC alone, CBD alone, THC+CBD, and placebo, and again the combination showed the clearest signal for pain relief and freedom from the single most bothersome symptom, whether that was nausea, light sensitivity, or sound sensitivity.

A few things temper the enthusiasm:

• Multicenter, large-scale randomized trials remain rare, so most of what is known comes from a handful of studies plus observational surveys.
• Cannabis products vary widely in formulation, so a result with one THC:CBD ratio does not automatically generalize to another.
• Individual response differs a lot, meaning what works for one person’s migraine may do nothing for another’s.

CBD alone tends to show a weaker acute effect than combinations that include THC, based on the same body of trial work, which is part of why balanced ratios keep showing up as the more reliable acute option.

When cannabis can worsen headaches instead of easing them

Cannabis is not risk-free for migraine, and the biggest concern is one that applies to almost any acute headache treatment: medication overuse headache, or MOH. MOH develops when acute symptomatic treatments are used too frequently, and it can turn episodic migraine into a more constant, harder-to-treat pattern. Guidance from the American Migraine Foundation flags using acute treatments more than 2 to 3 days per week as a red flag for overuse, and that threshold applies to cannabis just as it does to triptans or over-the-counter painkillers.

THC brings its own set of possible downsides:

• Anxiety or paranoia, especially at higher doses or in people who are new to THC.
• Dizziness or lightheadedness, which can compound the disorientation some people already feel during an attack.
• A rebound headache pattern in people who use high-THC products frequently for pain.
• Wide individual variation in sensitivity, meaning the same dose can feel mild to one person and intense to another.

The fix is not to avoid cannabis outright but to monitor use carefully. Keep a simple diary: date, product, dose, method, and how your symptoms changed over the next few hours. Look for patterns, such as headaches creeping earlier in the week or increasing in frequency, and treat that as a signal to pull back and loop in a healthcare provider.

Pro Tip: If your rescue product stops working as well as it used to, that is often a sign of overuse tolerance, not a sign you need a stronger dose.

Which cannabinoids and terpenes actually matter

Ratio matters more than strain name when you are choosing a product for migraine. A literature review on medical cannabis for headache and migraine points to phytocannabinoids helping reduce frequency and severity for some patients, particularly when first- and second-line medications have not worked, though the evidence is described as heterogeneous rather than uniform.

A practical way to think about ratios:

• CBD-dominant products suit prevention and people who are sensitive to THC’s psychoactive effects or prone to anxiety.
• Balanced ratios around 1:1 to 2:1 CBD:THC are the pattern most associated with acute daytime relief in trial settings, echoing the 6% THC and 11% CBD combination used in the Neurology trial.
• Low-dose THC-dominant products have a place for people who already tolerate THC well and need stronger acute relief, but they carry the highest risk of side effects and should be used sparingly.

Terpenes add another layer. Myrcene and beta-caryophyllene show up repeatedly in patient reports as helpful for pain and relaxation, according to the same PMC review, and beta-caryophyllene in particular has a reputation for anti-inflammatory activity that dovetails with migraine’s inflammatory component. Limonene, often prized for its uplifting citrus profile, is worth watching more carefully: some people report it aggravates their symptoms rather than easing them, so it is worth checking a product’s certificate of analysis (COA) before assuming a citrusy strain will help. You can see how terpene data appears on a real product page in the Wedding Cake strain guide, which lists cannabinoid and terpene percentages side by side.

Beyond THC and CBD, some people explore non-cannabinoid compounds like PEA (palmitoylethanolamide), which works through a different pathway tied to the body’s own fatty acid signaling rather than direct CB1 or CB2 activity. It is not a cannabis product, but it sometimes appears alongside cannabinoid discussions because the mechanisms, while distinct, both touch inflammation and pain modulation.

Choosing products by your dominant migraine symptom

Not every migraine attack looks the same, and the right product often depends on which symptom is hardest to manage.

1. Severe pain with nausea: A balanced THC:CBD vaporized product, dosed in small increments, tends to match the acute-relief pattern seen in the Neurology trial. Inhalation also sidesteps the nausea problem that makes swallowing a capsule or edible unappealing mid-attack.
2. Sleep loss and slow recovery: Indica-leaning products with myrcene and beta-caryophyllene-forward terpene profiles, taken as an edible or tincture, offer longer duration that can carry you through a disrupted night. The Cannalope Kush strain guide is a useful example of how a strain’s terpene profile lines up with a more sedating effect.
3. Frequent but lower-intensity days: A CBD-dominant tincture or capsule taken daily at a low, consistent dose fits a prevention strategy better than an as-needed rescue approach, and it avoids the overuse pattern tied to MOH.

Format choice matters as much as ratio. Surveys cited in the PMC literature review found inhalation is the most common route people choose for migraine and headache relief, likely because it acts fastest, while oral tinctures and edibles take longer to kick in but last longer, making them better suited to overnight coverage or steady prevention.

Whatever the format, the label and COA are where the real information lives:

• Check the exact THC and CBD percentages rather than relying on a strain’s reputation alone.
• Look for the terpene breakdown, especially myrcene, beta-caryophyllene, and limonene levels.
• Confirm the batch number matches the COA on file, since potency can shift between harvests even under the same strain name.
• Note the testing date, since cannabinoid content can degrade over time in improperly stored products.

The Cherry strain guide shows what this batch-level lab data looks like in practice, with cannabinoid and terpene figures tied to a specific tested batch rather than a generic average.

How to dose by method, step by step

Dosing cannabis for migraine works best as a slow, methodical process rather than guesswork, because overshooting the dose is one of the more common ways people end up with anxiety or worsened symptoms instead of relief.

1. Inhalation: Take one small puff, then wait a full 10 minutes before deciding whether to take a second. If relief has not started, one additional puff is reasonable, but stop there for that attack. Puffs work as the unit of measure here because inhaled cannabinoids act fast, within minutes, so there is no reason to stack multiple puffs before the first one has had a chance to work.
2. Tinctures: Start with about 2.5 mg of a CBD-forward or balanced tincture placed under the tongue, and wait 60 to 90 minutes before considering another dose. Sublingual absorption is slower than inhalation but faster than swallowing, which makes it a middle-ground option for people who cannot vape.
3. Edibles: Sensitive users should start at 1 to 2.5 mg of THC, or choose a CBD-forward or 1:1 formulation, and wait at least 2 hours before assuming it has not worked. Edibles are the slowest format and the easiest to overdo if someone redoses too early, so patience here matters more than with any other method.
4. Capsules: These follow a similar timeline to edibles and work well for a consistent daily prevention dose rather than acute rescue, since onset is not fast enough for an active attack.

Pro Tip: Never combine methods for the same attack, one puff plus a tincture plus an edible, without a clear log of what and when. Stacking formats without tracking is the fastest way to lose track of your actual dose.

A simple log, even a note on your phone, showing date, method, dose, and outcome makes it far easier to see whether you are creeping toward overuse or genuinely finding a working protocol.

Safety checklist and when to call a clinician

Before treating cannabis as a routine part of migraine management, run through a short mental checklist.

• Watch for interactions. The American Headache Society’s guidance on rational polypharmacy recommends caution when combining multiple migraine medications, including triptans, ergots, and ditans, because overlapping mechanisms can compound side effects rather than add benefit. Cannabis added on top of these without a clinician’s input falls into the same category of caution.
• Note your other medications. Bring a full list, including any preventive migraine drugs, to a conversation with your provider so they can flag anything that might interact.
• Share your tracking data. A usage diary with dose, method, timing, and outcome gives a clinician far more to work with than a vague description of “sometimes it helps.”
• Bring your COAs. If you can show a provider the lab results for the specific products you are using, they can better judge THC and CBD exposure rather than guessing from a strain name.

Reach out to a healthcare provider if your headache frequency increases, if you notice new anxiety or mood changes, or if you find yourself needing higher doses over time to get the same effect. These are all signs that the current approach needs adjusting rather than escalating.

Where this guidance comes from and how to verify it

Green On The Go operates as a licensed cannabis delivery service with a fully documented supply chain, meaning every product on the menu comes with verifiable lab results rather than a seller’s word alone.

• Every product is sourced through a legal, licensed supply chain with lab testing behind it.
• The curated menu features established California brands, chosen for batch consistency rather than the widest possible selection.
• Local drivers handle delivery across Alameda County, which keeps the process fast without cutting corners on verification.
• Strain guides on the site, including pages like the Chem Reserve strain guide, lay out cannabinoid and terpene data so readers can check a product’s profile before ordering.

Readers looking to confirm any of the ratios or terpene patterns discussed above can cross-reference a specific product’s COA directly on its page rather than relying on strain name alone.

What the evidence actually supports, and where advice overshoots it

The honest read of the evidence is that cannabis, specifically a balanced THC:CBD combination taken by inhalation, has real trial support for acute migraine relief, not just anecdote. That is a meaningfully stronger claim than most wellness content makes, and it deserves to be said plainly. Where a lot of popular advice overshoots is in treating “indica for pain, sativa for energy” as a reliable rule. Chemovar labels correlate loosely with effect at best, and the terpene and cannabinoid content of a specific tested batch tells you far more than whether a grower called it an indica or a sativa.

The bigger blind spot in most cannabis-and-migraine content is medication overuse headache. People are quick to celebrate cannabis as a natural alternative to pharmaceuticals and slow to apply the same overuse discipline they would expect from a doctor prescribing triptans. If you take one thing from this guide, track your rescue use like you would track any other acute medication, and treat frequent need as a signal to build a prevention plan, not a reason to increase the dose.

— Jake

Try a lab-tested product matched to your migraine pattern

Reading about the right ratio is one thing. Every item on the menu, from flower and pre-rolls to vaporizers, tinctures, edibles, and concentrates, comes from a licensed supply chain with lab results available, so you are not guessing at what is actually in the jar.

If you want to start with the CBD-forward or balanced approach discussed above, browsing the strain guide is the fastest way to compare terpene and cannabinoid profiles before you buy. When you know what you are looking for, same-day delivery across Alameda County brings it to your door without a dispensary trip.

• Lab results can be available to verify product batches.
• Delivery services may cover cities in Alameda County including Oakland, Berkeley, and Fremont.
• Products are sourced through California’s licensed legal supply chain.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

• Neurology (randomized trial of vaporized cannabis for migraine)
• Randomized trial: vaporized cannabis for acute migraine (PMC)
• Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature (PMC)

FAQ

What is the 3 drug cocktail for migraine?

Definitions vary depending on the clinic, but a commonly described acute combination pairs a triptan with an anti-inflammatory drug and an anti-nausea medication. This is a conventional pharmaceutical approach, distinct from the cannabis-based strategies covered in this guide, and any combination should be discussed with a prescribing clinician.

What do Japanese take for migraines?

This guide does not have sourced information on migraine treatment patterns specific to Japan. General migraine care typically includes over-the-counter or prescription pain relievers and, for frequent attacks, preventive medications prescribed by a physician.

What are the 5 C’s for migraines?

There is no single, widely recognized clinical framework called a multi-component system for migraine supported by the sources in this guide. Readers looking for a structured migraine management plan are better served by consulting the American Migraine Foundation or a headache specialist directly.

What’s better for migraines, Sativa or Indica?

Chemovar labels like sativa and indica are not reliable predictors of migraine relief on their own. The stronger evidence points to specific cannabinoid ratios, particularly balanced THC and CBD combinations shown in a randomized trial, and to terpene content such as myrcene or beta-caryophyllene rather than the sativa-indica distinction.

How often can I use cannabis for migraine without risking overuse headache?

Using acute cannabis treatments more than 2 to 3 days per week raises the risk of medication overuse headache, according to guidance from the American Migraine Foundation. If you are hitting that frequency regularly, it is worth discussing a preventive plan with a clinician instead of relying on rescue use.

Recommended

• Weed Delivery Alameda, CA | Same-Day Cannabis Delivery
• Weed Delivery Albany, CA | Same-Day Cannabis Delivery
• Weed Delivery Emeryville, CA | Same-Day Cannabis Delivery
• Cannabis Strain Guide